Frequently Asked Questions
The global hemophilia B market is projected to grow at a CAGR of 9% during the forecast period of 2022-2029.
The factors such as increasing awareness of hemophilia are acting as the major drivers for the global hemophilia B market.
North America dominates the market due to the high demand of diseases specific treatments, the rise in the adoption of newer technologies.
Asia-Pacific has been witnessing positive growth for the global hemophilia B market throughout the forecasted period due to increased patient awareness levels as well as the high prevalence of bleeding disorders.
